Eulerpool Terminal
The edge that pays for itself.
Current Monte Rosa Therapeutics forecasts and price targets in November 2026
Ø Analyst Price Targets
26.67 USD
+152.08 %
Median
27.00 USD
+155.20 %
Max
28.00 USD
Min
25.00 USD
Last Price
10.58 USD
Buy
15
Hold
1
Sell
0
The average target price for Monte Rosa Therapeutics is 26.67 USD. (+152.08 % above the current price)
The median price target of Monte Rosa Therapeutics is 27.00 USD.
Stock analysts from many renowned investment banks are closely examining the Monte Rosa Therapeutics stock. They conclude their professional Monte Rosa Therapeutics stock analyses with a clear recommendation for the Monte Rosa Therapeutics stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-11-01 | 15 | 1 | 0 | 26.67 USD |
| 2026-10-01 | 14 | 1 | 0 | 26.67 USD |
| 2026-09-01 | 14 | 1 | 0 | 26.67 USD |
| 2026-08-01 | 14 | 1 | 0 | 26.67 USD |
| 2026-07-01 | 14 | 1 | 0 | — |
| 2026-06-01 | 14 | 1 | 0 | — |
Monte Rosa Therapeutics Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Monte Rosa Therapeutics in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 72.00 M USD | -103.00 M USD | -1.57 USD |
| 2027e | 64.00 M USD | -135.00 M USD | -2.06 USD |
| 2028e | 124.00 M USD | -120.00 M USD | -1.83 USD |